Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 04 04:00PM ET
Dollar change
Percentage change
IndexRUT P/E28.56 EPS (ttm)0.53 Insider Own14.03% Shs Outstand105.26M Perf Week6.81%
Market Cap1.61B Forward P/E11.78 EPS next Y1.28 Insider Trans0.00% Shs Float91.65M Perf Month19.33%
Income62.04M PEG- EPS next Q0.28 Inst Own69.84% Short Float / Ratio7.26% / 5.44 Perf Quarter16.38%
Sales348.39M P/S4.61 EPS this Y-21.07% Inst Trans10.43% Short Interest6.66M Perf Half Y30.50%
Book/sh3.27 P/B4.61 EPS next Y115.88% ROA16.62% Target Price23.30 Perf Year-9.44%
Cash/sh1.13 P/C13.27 EPS next 5Y- ROE20.06% 52W Range11.09 - 22.11 Perf YTD-19.03%
Dividend- P/FCF- EPS past 5Y- ROI17.63% 52W High-31.89% Beta1.00
Dividend %- Quick Ratio3.17 Sales past 5Y4089.61% Gross Margin79.66% 52W Low35.80% ATR0.50
Employees82 Current Ratio3.32 Sales Q/Q79.39% Oper. Margin21.79% RSI (14)71.09 Volatility3.05% 3.61%
OptionableYes Debt/Eq0.01 EPS Q/Q-242.15% Profit Margin17.81% Rel Volume0.87 Prev Close14.82
ShortableYes LT Debt/Eq0.01 EarningsNov 08 AMC Payout0.00% Avg Volume1.22M Price15.06
Recom1.40 SMA2011.33% SMA5016.33% SMA2007.83% Volume1,065,471 Change1.62%
Date Action Analyst Rating Change Price Target Change
Aug-24-22Downgrade ROTH Capital Buy → Neutral $10 → $15.50
Sep-21-18Initiated Cantor Fitzgerald Overweight
Sep-07-18Resumed Piper Jaffray Overweight
Oct-05-16Upgrade Piper Jaffray Neutral → Overweight
Apr-26-16Downgrade Piper Jaffray Overweight → Neutral $6 → $1
Sep-30-14Reiterated ROTH Capital Buy $5 → $6
Sep-16-14Reiterated ROTH Capital Buy $3.50 → $5
Sep-15-14Reiterated H.C. Wainwright Buy $5 → $13
Oct-21-13Reiterated Aegis Capital Buy $4 → $5.50
Sep-24-13Initiated Maxim Group Buy $4
Today 08:03AM
Nov-16-23 08:05AM
Nov-09-23 06:10AM
Nov-08-23 04:11PM
Nov-02-23 10:37AM
10:00AM Loading…
Nov-01-23 10:01AM
Oct-30-23 08:03AM
Oct-26-23 03:19PM
Oct-23-23 08:03AM
Oct-19-23 08:03AM
Oct-16-23 08:03AM
Oct-13-23 08:03AM
Oct-12-23 09:50AM
08:03AM Loading…
Sep-18-23 08:03AM
Sep-08-23 11:30AM
Sep-06-23 01:06PM
Aug-16-23 10:56AM
Aug-14-23 08:05AM
Aug-11-23 06:09AM
Aug-09-23 05:50PM
Aug-03-23 02:44PM
Jul-25-23 08:03AM
Jul-24-23 08:03AM
Jul-23-23 10:21AM
Jul-19-23 06:00AM
Jul-05-23 05:50PM
01:46PM Loading…
Jul-02-23 01:46PM
Jun-29-23 05:50PM
Jun-23-23 05:50PM
Jun-21-23 08:00PM
Jun-20-23 06:00AM
Jun-19-23 09:30AM
Jun-14-23 05:50PM
Jun-09-23 11:30AM
Jun-01-23 09:30AM
May-30-23 08:03AM
May-22-23 08:15AM
May-12-23 09:30AM
May-11-23 08:41AM
May-10-23 05:55PM
May-09-23 08:03AM
May-03-23 05:45PM
May-01-23 08:03AM
Apr-27-23 05:45PM
Apr-26-23 08:00PM
Apr-24-23 05:50PM
Apr-20-23 12:26PM
Apr-18-23 05:50PM
Apr-14-23 11:30AM
Apr-12-23 05:50PM
Apr-11-23 09:45AM
Apr-07-23 07:30AM
Apr-05-23 10:15AM
Apr-04-23 05:50PM
Apr-03-23 12:45PM
Mar-27-23 05:50PM
Mar-22-23 09:55AM
Mar-21-23 05:50PM
Mar-17-23 09:30AM
Mar-16-23 12:45PM
Mar-15-23 05:25PM
Mar-13-23 06:30AM
Mar-10-23 09:00AM
Mar-09-23 10:00AM
Mar-08-23 11:20AM
Mar-01-23 08:03AM
Feb-28-23 06:30AM
Feb-27-23 05:50PM
Feb-24-23 12:45PM
Feb-22-23 08:03AM
Feb-21-23 05:50PM
Feb-15-23 09:30AM
Feb-13-23 05:50PM
Feb-08-23 12:45PM
Feb-07-23 08:03AM
Feb-06-23 05:50PM
Feb-03-23 09:00AM
Catalyst Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in developing and commercializing novel medicines for patients living with rare diseases including Lambert-Eaton myasthenic syndrome, congenital myasthenic syndromes, MuSK antibody positive myasthenia gravis, spinal muscular atrophy type 3, and infantile spasms. The company was founded by Huckel E. Hubert and Patrick J. McEnany in January 2002 and is headquartered in Coral Gables, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DENKHAUS DONALD ADirectorAug 03Option Exercise1.1360,00067,800393,000Aug 04 05:00 PM
MCENANY PATRICK JPresident and CEOMay 16Option Exercise0.79173,849137,3414,119,285May 17 05:04 PM
MCENANY PATRICK JPresident and CEOMay 15Option Exercise0.7926,15120,6593,971,587May 17 05:04 PM
MCENANY PATRICK JPresident and CEOMay 15Sale13.2326,151345,9783,945,436May 17 05:04 PM
Daly Richard JDirectorMay 12Option Exercise0.7950,00039,500148,000May 16 05:01 PM
Miller SteveChief Operating OfficerMay 11Option Exercise0.79100,00079,000687,457May 12 05:00 PM
Tierney David SDirectorMay 11Option Exercise0.7920,00015,800333,541May 12 05:01 PM
COELHO PHILIP HDirectorMay 04Option Exercise0.7950,00039,500204,887May 05 05:00 PM
Tierney David SDirectorApr 05Option Exercise0.7930,00023,700343,541Apr 07 05:00 PM
Tierney David SDirectorApr 05Sale16.8330,000504,900313,541Apr 07 05:00 PM
Del Carmen JeffreyChief Commercial OfficerMar 29Option Exercise3.1840,000127,06328,524Mar 30 05:01 PM
GRANDE ALICIAVP, Treasurer and CFOMar 29Option Exercise1.1350,00056,500100,557Mar 30 05:00 PM
GRANDE ALICIAVP, Treasurer and CFOMar 29Sale16.7050,000835,10050,557Mar 30 05:00 PM
Del Carmen JeffreyChief Commercial OfficerMar 29Sale16.7040,000667,8107,541Mar 30 05:01 PM
GRANDE ALICIAVP, Treasurer and CFOMar 28Option Exercise0.7958,21645,991108,773Mar 30 05:00 PM
GRANDE ALICIAVP, Treasurer and CFOMar 28Sale16.5458,216962,78650,557Mar 30 05:00 PM
GRANDE ALICIAVP, Treasurer and CFOMar 22Option Exercise0.7941,78433,00989,081Mar 24 05:00 PM
GRANDE ALICIAVP, Treasurer and CFOMar 22Sale16.5041,784689,52850,557Mar 24 05:00 PM
Elsbernd BrianChief Compliance/Legal OfficerMar 20Option Exercise1.1350,00056,500188,076Mar 22 04:45 PM
Elsbernd BrianChief Compliance/Legal OfficerMar 20Sale16.0750,000803,450138,076Mar 22 04:45 PM
DENKHAUS DONALD ADirectorJan 24Option Exercise0.7950,00039,500329,000Jan 27 04:30 PM
O'Keeffe Charles BDirectorJan 24Option Exercise0.7950,00039,500616,391Jan 27 04:30 PM
INGENITO GARYChief Medical OfficerDec 06Sale16.855,91899,71830,802Dec 08 05:03 PM